Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.
Los Angeles Times (Home Edition); Monday August 25, 1997 Page B-5
Diane Watson; Sen. Diane Watson (D-Los Angeles), a state senator since 1978, chairs the Senate Health and Human Services Committee
In the African American community, the epidemic of injection-related AIDS cases cries out for healing of the literal kind.
AIDS is the No. 1 killer of blacks between 25 and 44. Half of those deaths can be traced to intravenous drug use. Science tells us that needle exchange is effective prevention, yet national and state legislation currently prevents its widespread adoption.
As of December 1996, 32% of the 573,000 reported AIDS cases in the U.S. were linked to injected drugs; 100,000 of them were African Americans. Needle use is the primary source of transmission among heterosexuals and accounts for about 90% of AIDS cases among women. By the end of 1996, 29,700 black women had injection-related AIDS or had died from it.
Injection drug use is also responsible for the majority of cases involving HIV transmission between mothers and their infants. Of the 6,891 pediatric AIDS cases related to a mother with or at risk of HIV injection, 59% were related to injection drug use. For a host of reasons, injection-related HIV transmission disproportionately affects the African American community.
Policymakers have traditionally cited strong anti-drug sentiments within the black community as reasons to shy away from needle exchange legislation. But in this rare instance, politicians aren't looking closely enough at the polls.
Sixty-six percent of all Americans and 69% of African Americans are in favor of needle exchange programs, according to a 1996 Kaiser Family Foundation survey. A preponderance of scientific data backs them up:
* A Yale University study of a needle exchange program in New Haven estimates that in the first eight months of operation, the program reduced new HIV infections by 33%.
* Needle exchange programs have been shown to reduce needle sharing by 80%, cutting down the number of contaminated needles in circulation.
* Needle exchange programs do not attract new drug users nor do they increase the frequency of injection among program participants.
To make needle exchange programs a key component of our national AIDS prevention strategy, we must lift the federal ban on funding. Currently there are only 117 programs operating in 72 cities. Many of them must depend on volunteers.
We need to establish needle exchange pilot projects in the 10 states, including California, where the furnishing, possession or use of hypodermic needles or syringes without a prescription is now criminalized. A bill I am sponsoring would allow pharmacists, physicians and other authorized individuals to provide injection equipment without a prescription in targeted California cities.
President Clinton and legislators who who want to do the right thing for race relations and the black community would do well to listen to what African Americans and the majority of Americans have to say: Lift legislative restrictions on needle exchange now. The best way to prevent a powder keg from exploding is to snuff the fuse.
PHOTO: DIANE WATSON
Copyright © 1997 - Los Angeles Times. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Los Angeles Times, Permissions, Times Mirror Square, Los Angeles, CA 90053. http://www.latimes.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .